Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Filings indexed 627 across all filing types
Latest filing 2017-12-19 Regulatory Filings
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
8-A12B
Regulatory Filings
2017-12-19 English
6-K
Regulatory Filings
2017-12-11 English
QIAGEN to transfer U.S. listing of global shares to NYSE
Delisting Announcement Classification · 99% confidence The document is a press release dated December 8, 2017, announcing that QIAGEN N.V. is transferring its U.S. stock listing from NASDAQ to the NYSE, effective around January 10, 2018. This is a corporate action announcement related to stock exchange listing, which is a form of capital structure or corporate event communication. It is not a full annual report (10-K), an earnings release (ER), or a detailed financial report (IR). Since it involves a change in the listing venue, it falls under corporate financing or structural announcements. Among the provided codes, 'CAP' (Capital/Financing Update) is the closest fit for a major stock exchange listing change, as it affects the capital market presence and structure. It is not a standard regulatory filing like 10-K or a general announcement (RNS), but a specific corporate event announcement.
2017-12-11 English
6-K
Regulatory Filings
2017-11-07 English
6-K
Regulatory Filings
2017-11-07 English
SC 13G/A
Major Shareholding Notification
2017-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.